The change on the ground
An MIT postdoc in a cell biology lab used to face a decision that had little to do with the science. When a manuscript came back accepted from an Elsevier journal, the corresponding author had to choose whether to pay an article processing charge (APC) from a grant, bill it to a lab account, or publish behind a subscription paywall. For 2026, that decision changes. Under the read-and-publish agreement between MIT and Elsevier, corresponding authors at MIT can make articles open access in a defined set of journals without an APC routed through the lab.
The arrangement is not a return to the old subscription-only model. It bundles reading access to Elsevier titles with open access publishing for MIT-affiliated corresponding authors. The practical effect is that the author's institutional relationship, not a case-by-case funding decision, determines whether an accepted article can be published open access at no direct charge to the author.
Why MIT held out
MIT has not had a standard direct Elsevier contract since 2020, when the institute declined to renew under terms it said failed the MIT Framework for Publisher Contracts. That framework, adopted in 2019, set conditions that have shaped library negotiations far beyond Cambridge, Massachusetts. It called for contracts without nondisclosure agreements, retention of author rights, transparent pricing, and a path to open access.
For several years MIT operated without full ScienceDirect access. Researchers used interlibrary loan, document delivery, open access versions, and alternative routes to get articles. The decision made MIT one of the most visible American holdouts, even as peers settled. The University of California reached a four-year transformative agreement with Elsevier in 2021, and Carnegie Mellon signed a read-and-publish deal in 2020. MIT's stance drew attention because it treated the absence of a contract as viable, not as a failure.
How read-and-publish works
A read-and-publish agreement, sometimes called a transformative agreement, merges two costs that used to be separate: the subscription fee for reading and the APC for publishing open access. One institutional payment covers both. For an eligible MIT corresponding author who submits to an included journal, the publishing charge is handled centrally rather than billed individually.
The MIT Libraries page for the MIT Framework for Publisher Contracts spells out the principles MIT negotiators use. The distinction between a read-and-publish deal and a pure subscription matters because the latter leaves APCs in place, which means open access remains a fee-for-service arrangement layered on top of the subscription. The former moves the institution's payment toward publishing output. AcademicJobs has covered similar contract tensions elsewhere, including the UK higher education sector's disputes with Elsevier over price and access terms.
What the included title list means for authors
The title list decides whether the agreement actually reaches a specific researcher. Elsevier publishes more than 2,800 journals, and read-and-publish agreements usually name a subset of included titles. A corresponding author should check, before submission, whether the target journal is covered for publishing and whether the agreement applies to the article type. Not every journal in the portfolio may be included, and some titles may have separate arrangements.
For the postdoc in the cell biology lab, the checklist is concrete rather than abstract:
- Is the target journal on the 2026 MIT-Elsevier included title list?
- Does the open access option apply to the article type the lab is submitting?
- Which reuse licence will apply, and who chooses it?
- Will the author retain copyright under the agreement, or does the licence rest with the publisher?
Each of these details is knowable before submission. The risk for authors is assuming all Elsevier journals participate when only some do.
The money question behind the agreement
Read-and-publish agreements do not eliminate cost; they rebundle it. MIT's framework asked for transparent pricing, and the institute has historically declined contracts where the publisher would not allow financial terms to be assessed openly. Whether the 2026 Elsevier agreement meets that standard will be a focus for faculty governance bodies and library analysts. The total cost is typically based on a reading fee plus projected publication output, which means institutions with high research volume can end up paying more than previous subscription-only invoices, even as individual authors stop seeing APC line items.
SPARC, a coalition that advocates for open access and library interests, maintains resources explaining how these agreements shift institutional money from subscriptions to publishing. Its read-and-publish resource page is a useful starting point for faculty who want to see the mechanism rather than the press release. The problem with cost-per-article calculations under read-and-publish deals is that they depend on productivity assumptions that can change from one year to the next.
What critics are watching
Open access advocates have long argued that read-and-publish agreements lock in the market power of large publishers rather than shifting money to community-owned or institutional journals. The criticism applies to MIT's decision even after years of resistance. A deal with Elsevier normalises Elsevier's position in the campus publishing budget and may reduce the pressure that MIT's absence once created. The university's decision to hold out after 2020 forced conversations about document delivery and alternative access; a signed 2026 agreement changes that dynamic.
There is also an equity issue. Corresponding authors at institutions without such agreements still face APCs, which means the geography of open access publishing continues to depend on institutional wealth. This was one of the concerns raised in earlier reporting by AcademicJobs on Plan S journal price transparency efforts and remains unresolved in most read-and-publish contracts.
The measurement that should come next
The clearest test of the 2026 arrangement will appear in the data MIT Libraries reports after the first year. A small set of figures matters most: the share of eligible MIT articles that become open access rather than remaining paywalled, the number of open access articles per dollar compared with the old subscription-plus-APC path, the distribution of publishing across journals inside and outside Elsevier's title list, and the share of open access articles that carry a non-commercial reuse licence.
For the postdoc in the cell biology lab, those numbers will feel distant. What she will notice is simpler. When the acceptance email arrives, the open access decision will already be made by the institution's contract rather than by the lab's remaining grant balance. That is a real shift. Whether it shifts the broader publishing economy remains a question for the data.
Photo by Alexander Grey on Unsplash